Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Nicholas Butowski, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Nicholas Butowski, MD
Professor, Neurological Surgery. Authored (or co-authored) 106 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Orbus Therapeutics, Inc.
- ID
- NCT02796261
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated